These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17045472)

  • 1. Equating EORTC QLQ-C30 and FACT-G scores and its use in oncological research.
    Holzner B; Bode RK; Hahn EA; Cella D; Kopp M; Sperner-Unterweger B; Kemmler G
    Eur J Cancer; 2006 Dec; 42(18):3169-77. PubMed ID: 17045472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability and sample size requirements of quality-of-life measures: a randomized study of three major questionnaires.
    Cheung YB; Goh C; Thumboo J; Khoo KS; Wee J
    J Clin Oncol; 2005 Aug; 23(22):4936-44. PubMed ID: 16051946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. French version of FACT-G: validation and comparison with other cancer-specific instruments.
    Conroy T; Mercier M; Bonneterre J; Luporsi E; Lefebvre JL; Lapeyre M; Puyraveau M; Schraub S
    Eur J Cancer; 2004 Oct; 40(15):2243-52. PubMed ID: 15454249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients.
    Cankurtaran ES; Ozalp E; Soygur H; Ozer S; Akbiyik DI; Bottomley A
    Eur J Cancer Care (Engl); 2008 Jan; 17(1):98-104. PubMed ID: 18181898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
    Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
    Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating cognitive, emotional, and physical fatigue domains in daily practice by single-item questions in patients with advanced cancer: a cross-sectional pragmatic study.
    Strasser F; Müller-Käser I; Dietrich D
    J Pain Symptom Manage; 2009 Oct; 38(4):505-14. PubMed ID: 19822275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.
    Kemmler G; Holzner B; Kopp M; Dünser M; Margreiter R; Greil R; Sperner-Unterweger B
    J Clin Oncol; 1999 Sep; 17(9):2932-40. PubMed ID: 10561373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
    Greimel ER; Kuljanic Vlasic K; Waldenstrom AC; Duric VM; Jensen PT; Singer S; Chie W; Nordin A; Bjelic Radisic V; Wydra D;
    Cancer; 2006 Oct; 107(8):1812-22. PubMed ID: 16977652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two quality of life instruments for cancer patients: the Ferrans and Powers Quality of Life Index and the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire C30.
    Gupta D; Grutsch JF; Lis CG
    J Soc Integr Oncol; 2008; 6(1):13-8. PubMed ID: 18302906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26.
    Fitzsimmons D; Kahl S; Butturini G; van Wyk M; Bornman P; Bassi C; Malfertheiner P; George SL; Johnson CD
    Am J Gastroenterol; 2005 Apr; 100(4):918-26. PubMed ID: 15784041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Mexican Spanish version of the EORTC C30 and STO22 questionnaires for the evaluation of health-related quality of life in patients with gastric cancer.
    Oñate-Ocaña LF; Alcántara-Pilar A; Vilar-Compte D; García-Hubard G; Rojas-Castillo E; Alvarado-Aguilar S; Carrillo JF; Blazeby JM; Aiello-Crocifoglio V
    Ann Surg Oncol; 2009 Jan; 16(1):88-95. PubMed ID: 18979141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation and comparison of the health-related quality-of-life instruments EORTC QLQ-C30 and SF-36 in assessment of patients with chronic nonmalignant pain.
    Fredheim OM; Borchgrevink PC; Saltnes T; Kaasa S
    J Pain Symptom Manage; 2007 Dec; 34(6):657-65. PubMed ID: 17618079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The European Organization for Research and Treatment of Cancer core quality of life questionnaire (QLQ-C30 version 3.0 Turkish) in cancer patients receiving palliative radiotherapy.
    Hiçsönmez A; Köse K; Andrieu MN; Güney Y; Kurtman C
    Eur J Cancer Care (Engl); 2007 May; 16(3):251-7. PubMed ID: 17508945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validating and improving the reliability of the EORTC qlq-c30 using a multidimensional Rasch model.
    Shih CL; Chen CH; Sheu CF; Lang HC; Hsieh CL
    Value Health; 2013; 16(5):848-54. PubMed ID: 23947980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life scores differed according to mode of administration in a review of three major oncology questionnaires.
    Cheung YB; Goh C; Thumboo J; Khoo KS; Wee J
    J Clin Epidemiol; 2006 Feb; 59(2):185-91. PubMed ID: 16426954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EORTC QLQ-C30 and FACT-Lym for the assessment of health-related quality of life of newly diagnosed lymphoma patients undergoing chemotherapy.
    Georgakopoulos A; Kontodimopoulos N; Chatziioannou S; Niakas D
    Eur J Oncol Nurs; 2013 Dec; 17(6):849-55. PubMed ID: 23850411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient preference for either the EORTC QLQ-C30 or the FACIT Quality Of Life (QOL) measures: a study performed in patients suffering from carcinoma of an unknown primary site (CUP).
    Rodary C; Pezet-Langevin V; Garcia-Acosta S; Lesimple T; Lortholary A; Kaminsky MC; Bennouna J; Culine S; Bourgeois H; Fizazi K
    Eur J Cancer; 2004 Mar; 40(4):521-8. PubMed ID: 14962718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Utility of the questionnaire for quality of life EORTC-QLQ-C30 in psycho-oncological outcome research].
    Determann MM; Kollenbaum VE; Henne-Bruns D
    Zentralbl Chir; 2004 Jan; 129(1):14-7. PubMed ID: 15011106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The EORTC QLQ-HDC29: a supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation.
    Velikova G; Weis J; Hjermstad MJ; Kopp M; Morris P; Watson M; Sezer O;
    Eur J Cancer; 2007 Jan; 43(1):87-94. PubMed ID: 17081744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.